Frequently asked questions on medicinal products marketing authorisation

Frequently asked questions on medicinal products marketing authorisation

The State Agency of Medicines (SAM) of Latvia launches a new subsection on the Agency’s web page Frequently asked questions under the section Services – Human Medicines: Authorisation, Renewal, Variations . In order to addresses a number of questions that have been brought to the attention of the SAM by Marketing Authorisation Holders (MAHs) on matters related to quality of medicinal products a new subsection was developed. It provides harmonised position on issues that can be subject to different interpretation or require clarification, typically arising from discussions or correspondence during assessment procedures. Information under this subsection will be updated regularly.